Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets

Diffuse large B cell lymphoma (DLBCL) is the most common type of lymphoma worldwide, representing 30–40% of non-Hodgkin lymphomas, and is clinically aggressive. Although more than half of patients with DLBCL are cured by using standard first-line immunochemotherapy, the remaining patients are refrac...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Yi, Medeiros, L. Jeffrey, Xu-Monette, Zijun Y., Li, Jianyong, Young, Ken H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406015/
https://www.ncbi.nlm.nih.gov/pubmed/30881917
http://dx.doi.org/10.3389/fonc.2019.00107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406015/
https://www.ncbi.nlm.nih.gov/pubmed/30881917
http://dx.doi.org/10.3389/fonc.2019.00107

Ejemplares similares